Ivacaftor: A Novel Mutation Modulating Drug
Cystic fibrosis (CF) is multisystemic disorder presenting in newborn period to adulthood, predominantly affecting respiratory system. It is caused by mutation in CF transmembrane conductance regulator gene. ∆F508 is the most common mutation seen worldwide. Supportive management with bronchodilator...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JCDR Research and Publications Private Limited
2014-11-01
|
| Series: | Journal of Clinical and Diagnostic Research |
| Subjects: | |
| Online Access: | https://jcdr.net/articles/PDF/5158/6486_CE(Ra)_F(Sh)_PF1(PAK)_PFA(Sh)_PFA1(Sh).pdf |